Is Thermo Fisher Scientific Inc. overvalued?

Thermo Fisher Scientific Inc. (TMO) looks overvalued — trading about 9% above its fair value.

Overvalued

Price

$603.01

Fair value

$547.05

Current P/E

34.0

Normal P/E

30.8

Market cap

$224.09B

Dividend yield

0.3%

Return on equity

13.4%

Sector

Healthcare

Fair value compares TMO's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 11 Aug 2026.

Related stocks